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What is known about embryonic testis morphogenesis?

Abstract
Many scientists have expended efforts to determine what regulates development of an indifferent gonad into either a testis or ovary. Expression of Sry and upregulation of Sox9 are factors that initiate formation
of the testis-specific pathway to allow for both sex-specific vasculature
and seminiferous cord formation. Migration of mesonephric precursors of peritubular myoid cells and endothelial cells into the differentiating testis is a critical step in formation of both of these structures.
Furthermore, these events appear to be initiated downstream from Sry
expression. Sertoli cell secretion of growth factors acts to attract these
mesonephric cells. One hypothesis is that a growth factor specific for
these cell linages act in concert to coordinate migration of both peritubular and endothelial cells. A second hypothesis is that several growth
factors stimulate migration and differentiation of mesonephric “stemlike” cells to result in migration and differentiation into several different cell lineages. While the specific mechanism is unclear, several
growth factors have been implicated in the initiation of mesonephric
cell migration. This review will focus on the proposed mechanisms of
a growth factor, Vascular Endothelial Growth Factor, and how different angiogenic and inhibitory isoforms from this single gene may aid
in development of testis-specific vascular development.

In the mouse, the Sry gene is expressed in embryos at
10.5 days post-coitus (dpc) and ceases after 12.5 dpc. Sry
induces expression of genes which cause differentiation of
the Sertoli cell lineage from precursor somatic cells in the
coelomic epithelium (Figure 1) (Cupp and Skinner 2005).
So even though Sry function is important, expression in the
rodent is brief. The Sertoli cell is the first cell of the testis
to differentiate (Magre and Jost 1991). After differentiation,
Sertoli cells begin to proliferate and simultaneously move
into the gonad proper, forming aggregates with primordial
germ cells. Proliferation of Sertoli cells increases the size of
the testis, and this proliferation appears to be solely dependent on the expression of Sry (Schmahl et al. 2000). Without
differentiation and proliferation of the Sertoli cells, the indifferent gonad would not develop into a testis.
After Sertoli cell differentiation, testicular cords and sexspecific vasculature develop to establish adult testis morphology. In the mouse, these events occur during 11.5–
12 dpc and are complete by 12.5 dpc while in the rat these
events occur between embryonic day 13.5–14 (Martineau
et al. 1997). Induction of cord formation is initiated by cell
migration from the adjacent mesonephros into the developing testis to surround the primordial germ and Sertoli
cell aggregates (Buehr et al. 1993; Merchant-Larios et al.
1993). Mesonephric cell migration is the result of Sry regulated expression of paracrine growth factors secreted by
Sertoli cells (Martineau et al. 1997). Paracrine growth factors act as chemo-attractants inducing mesonephric cell
migration and cord formation (Ricci et al. 1999; Cupp et al.
2000, 2002, 2003; Colvin et al. 2001). If mesonephric cell migration is blocked, or if the mesonephros is removed, no
cords will form. The population of cells that migrate from
the mesonephros is proposed to be pre-endothelial and/
or pre-peritubular cells (Buehr et al. 1993; Merchant-Larios
et al. 1993). Therefore, in addition to surrounding the Sertoli-primordial germ cell aggregates to form testis cords,
the migrating mesonephric cells may also initiate the formation of vasculature within the developing testis. Platelet-derived growth factor (Uzumcu et al. 2002a) and VEGF
(Bott et al. 2006) have been demonstrated to be necessary
for cord formation; however, only VEGF has been demonstrated to be critical for both vascular development and
cord formation.

Introduction
Why study gonadal differentiation and sex-specific vascular
development?
Infertility affects 40–70 million couples; of those approximately 50% of the infertility problems are attributed to
male-related factors which include: low sperm count, abnormal spermatogenesis, and reduced androgen production (Skakkebaek 2004). In the past 12 years, the incidence
of male infertility cases has increased at an alarming rate
resulting in the development of a new syndrome—testicular dysgenesis syndrome. The reasons for the increase in
testicular abnormalities are not understood but may be a
result of genetic or environmental disruption of cell differentiation during testis morphogenesis (Skakkebaek 2004).
Formation of testicular cords, and sex-specific vasculature,
are the two morphological hallmarks that distinguish a testis from an ovary. Testis development is initiated by Sertoli
cell differentiation and expression of Sry, causing mesonephric cell migration into the differentiating testis to form
seminiferous cords. Removal of the mesonephros or blockage of mesonephric cell migration prevents cord formation.
Thus, the migration of mesonephric derived cells, which
include pre-endothelial and pre-peritubular cells, are critical to testis development.
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Figure 1. Sry-regulated events occurring during sex determination and testis morphogenesis using days post-coitum and tail somites as
developmental markers (modified from Cupp
and Skinner 2005)

What is known about formation of sex-specific vascular
development?
Very little is known about what regulates sex specific vascular development in the gonads. Pre-endothelial cells
in the indifferent gonad express markers for both veins
(EphB4) and arteries (ephrin B2); however this changes as
each gonad develops sex-specific structures. In the testis,
endothelial cells migrate from the mesonephros and form
vascular networks with arterial markers between cords
and the coelomic vessel. The coelomic vessel is the major
testicular artery that is formed when mesonephric endothelial cells migrate from the mesonephros into the testis
and is unique to the testis. As endothelial cells differentiate a greater percentage develop into arteries and contribute to the coleomic vessel than those which contribute to
veins within the testis. The development of arteries may
be necessary to aid movement of testosterone to the developing male reproductive tract which allows for its maintenance and differentiation (Brennan et al. 2002). In contrast,
the ovary develops similar amounts of arterial and venous
networks from endothelial cells.
The origin of vasculature is different in the testis and
ovary with vascular networks developing through angiogenesis (branching from existing vasculature in the mesonephros) in the testis and through vasculogenesis (de novo
or neovascularization) in the ovary (Brennan et al. 2002). It
is likely that the testis and ovary develop vascular patterns
from different endothelial cell origins due to expression of
sex-specific transcription factors. Furthermore, sex-specific
transcription factors stimulate different growth factors to not
only initate blood vessel formation but organ-specific support structures such as seminiferous cords or oogonial cysts.
Experiments using knockout mice demonstrate that disruption of vascular development also causes sex-reversal
and abnormalities in germ cell development. Mice that are
null for Wnt4 (Jeays-Ward et al. 2003) and Follistatin (Fst)
(Yao et al. 2004) have sex-reversed XX gonads with ectopic
expression of a coelomic vessel and vasculature surrounding seminiferous cord-like structures. The Wnt4 gene regulates expression of Fst so it is not surprising that mice
null for both of these genes have the same phenotype. Follistatin is only expressed in the XX gonad and in general
acts to inhibit activins. Therefore, there is potential for ac-

tivins to be involved in formation of the coelomic vessel.
In contrast Inhibin beta b (Inhbb) XY null mice do not form
coelomic vessels 50% of the time. Thus, Inhbb null XY gonads are sometimes sex-reversed to XX vascular phenotypes. Activin A is composed of two inhibin beta a, Inhba,
subunits while Activin B is composed of two Inhbb subunits. In the ovary, only Inhbb is expressed and not Inhba.
Furthermore, expression of Inhbb is fourfold higher in the
testis compared to the ovary at 12.5 dpc. Mating of Wnt4
and Inhbb null mice recapitulate the normal phenotype in
XY gonads to form a coelomic vessel. Yet, matings between
Inhbb and Fst null mice did not recapitulate the XY vascular phenotype, thus Wnt4 suppression of Inhbb appears to
be independent of Fst inhibitory actions on activins (JeaysWard et al. 2003; Yao et al. 2006).
During normal testis development, Sry antagonizes expression of Wnt4 to suppress Fst and relieve inhibition of
Inhbb (Figure 2). We can only speculate that Inhbb transcriptional regulation is due to expression of Sox-9, or other
growth factors downstream of Sry expression. Inhbb stimulates endothelial cell migration and formation of a coelomic vessel. In XX gonads with no Wnt4 repression, Fst
expression is increased and Inhbb expression is down regulated to prevent endothelial cell migration and formation
of ovarian-specific vascular patterns (Yao et al. 2004).

Figure 2. Genes demonstrated to be involved in sex-specific
vascular patterns through development of null mice or treatment of indifferent gonads in organ culture

312

Bott, Clopton, & Cupp

Figure 3. Exons in VEGF gene that compose each VEGF
isoform.

In addition to the potential actions of Activin B, XX gonads treated with bone morphogenic proteins (BMP), antimullerian hormone (AMH) and Activin A in vitro developed a sex-reversed phenotype with formation of an ectopic
coelomic vessel; however, AMH deficient mice did not develop this same phenotype (Ross et al. 2003; Yao et al. 2004).
Bone morphogenic protein, AMH, Activin A and Inhbb
are members of the transforming growth factor-beta (TGFβ) superfamily and directly regulate cell function through
inhibition or activation of the SMAD signal transduction
pathway. In the zebrafish, SMAD response elements in the
promoter region of Vegfa gene also appear to regulate expression of different isoforms (He and Chen 2005). Thus,
the Vegfa gene may be a downstream gene regulated by
members of the TGF family to regulate sex-specific vasculature in the developing gonad (Figure 2).
What is known about the vascular endothelial growth factor
family?
The VEGF family is composed of five ligands: VEGF (VEGFA), VEGF-B, VEGF-C, VEGF-D and placenta growth factor.
VEGF (VEGF-A) is the best characterized and most potent
VEGF molecule. VEGF works through both Fms-like tyrosine kinase 1 (FLT1) and Kinase domain region receptor
(KDR), to elicit its effects on endothelial cell migration, differentiation, proliferation and survival and apoptosis. The
primary receptor involved in neovascularization of organs
with VEGF is KDR which contains a tyrosine kinase signal
transduction domain (Waltenberger et al. 1994). There are
conflicting reports about the role of FLT1 in regulation of
VEGF’s actions. In Flt1 knockouts, the mice die due to vasculature overgrowth suggesting that FLT1 acts as a decoy
receptor to inhibit VEGF-dependent vascular development.
Furthermore, FLT1 can also inhibit VEGF’s actions by dimerizing with KDR to inhibit signal transduction. Thus,
FLT1 appears to act as a negative regulator of VEGF’s actions on endothelial cell migration, survival and proliferation (Ferrara 2000; Olsson et al. 2006).
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Both mRNA and protein for VEGF and KDR are present during testis morphogenesis and are expressed in cells,
like the Sertoli cell, that direct testis development. However, Flt1 is not expressed until after cord formation in the
testis (Bott et al. 2006). The absence of FLT1 during mesonephric endothelial cell migration and establishment of
vasculature in the testis may allow for endothelial cell migration through VEGF. In contrast, the ovary, which does
not have mesonephric cell migration, expresses both Flt1
and Kdr during development (Pohlmann et al. 2004). Thus,
VEGF angiogenic isoforms may be bound by FLT1 receptor in the ovary inhibiting the ability of mesonephric endothelial cells to be recruited into the developing ovary;
thus providing a different endothelial cell origin for ovarian vasculature.
Vascular endothelial growth factor is transcribed from a
single gene that has eight exons and is alternatively spliced
into different isoforms each containing a different number
of amino acids. The most common angiogenic isoforms are
VEGF205, 188, 164, 144 and 120 (in humans the angiogenic
isoforms are one amino acid longer; Figure 3). The predominant isoforms expressed in tissues are VEGF188, 164 and
120 (Veikkola and Alitalo 1999).
In 2002, an additional isoform, VEGF165b, was identified which contained part of the 3’ UTR that is now determined to be exon 8b (Figure 3). Furthermore, recent studies have demonstrated that the human VEGF165b isoform
is anti-angiogenic in function and inhibits signal transduction through KDR (Bates et al. 2002; Woolard et al. 2004).
Thus, this isoform is inhibitory to the actions of VEGF. Recently several other inhibitory isoforms have been identified in the human and we have cloned several in both the
rat and bovine (VEGF165b accession number EU040284;
VEGF189b accession number EU040285). Therefore, it appears that for every angiogenic isoform there is a sister inhibitory isoform that is formed when exon 8a is replaced
with exon 8b. (In rodents and cattle the sister inhibitory
isoform is one amino acid longer.) The primary functions
of angiogenic VEGF isoforms are to induce endothelial cell
migration, survival, proliferation and differentiation to initiate angiogenesis within developing organs and tumors.
The inhibitory VEGF isoforms appear to modulate these
functions.
In addition to the multiple VEGF isoforms, two co-receptors, neuropilin1 (NRP1) and neuropilin2 (NRP2), that
bind to specific VEGF isoforms (i.e. VEGF164, VEGF188)
have been identified. The predominant function of NRP1
appears to be stabilization of VEGF164 binding to KDR
which augments signal transduction. The two co-receptors can also stabilize binding of VEGF isoforms to FLT1.
In fact, FLT1 may regulate VEGF actions by tying up NRP
bound isoforms. While both NRP co-receptors can bind to
FLT1 it appears that only NRP1 can stabilize signal transduction through KDR. Interestingly, KDR, but not FLT1 is
expressed during seminiferous cord formation (Bott et al.
2006) thus the ability of NRP1 to enhance signal transduction upon binding of VEGF isoforms to KDR may be critical during testis differentiation.
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What Signal Transduction Pathways Does VEGF
Activate Through KDR and Which Are Critical for
Testis Cord Formation?
Vascular endothelial growth factor induces the activation
of several signal transduction pathways upon binding to
KDR. Of these pathways, Phospholipase C gamma activates protein kinase C causing activation of Ras or Raf and
ultimately MAPK and ERK phosphorylation. The result of
ERK phosphorylation is endothelial cell proliferation (Shu
et al. 2002). The PI3-kinase pathway has been demonstrated
to affect migration and permeability through Rac and permeability and survival through Akt (Gerber et al. 1998). The
p38MAPK and FAK pathways are also postulated to affect
actin reorganization and focal adhesion turnover to influence migration (Goligorsky et al. 1999). Several of these
VEGF signal transduction pathways may interact to initiate
endothelial cell differentiation, migration, proliferation and
survival. Inhibition of the MAPK pathway affects cord formation (Uzumcu et al. 2002b) in testis organ cultures; however, PI3-kinase inhibits both seminiferous cord formation
(Uzumcu et al. 2002b; Bott et al. 2006) and vascular development (Bott et al. 2006). Thus, both of these sex-specific
events, vascular development and cord formation may be
regulated by multiple growth factors through a similar signal transduction pathway.
What specific roles do the VEGF isoforms have in endothelial cell
migration?
Endothelial cell recruitment and chemoattraction requires
several different VEGF isoforms to establish a VEGF concentration gradient. At least three of the angiogenic VEGF
isoforms are associated with specific endothelial cell functions (Veikkola and Alitalo 1999). VEGF120, a highly diffusible isoform, recruits endothelial cells into tissue to initiate the development of vasculogenesis while VEGF164
can recruit endothelial cells and establish large blood vessels. VEGF188, due to its heparin binding domain, acts
locally to induce branching of large blood vessels into
smaller capillaries and the development of capillary beds
(Grunstein et al. 2000) (Figure 3). Furthermore, these three
isoforms are thought to establish a VEGF chemoattractant
gradient to allow for endothelial cell migration. In the testis, VEGF120, 188 and 164 are present during seminiferous
cord formation and can develop a viable chemoattractant
gradient (Bott et al. 2006). In contrast, in the ovary only
VEGF164 and 120 are present (Pohlmann et al. 2004). The
absence of the larger VEGF isoforms to anchor the chemoattractant gradient inhibits endothelial cell migration
and weakens the attraction to VEGF secreting cells (Ruhrberg 2003). Therefore, in the ovary a viable chemoattractant gradient may not be present contributing to the lack
of mesonephric cell migration.
VEGF165b is anti-angiogenic and appears to inhibit the
actions of VEGF164 and to a lesser extent other VEGF isoforms. The inhibitory isoform, VEGF165b is expressed in all
tissues but is down-regulated in prostate tumors (Woolard
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et al. 2004), renal tumors (Bates et al. 2002) and in disorders
of the eye such as macular degeneration (Perrin et al. 2005).
The mechanism of differential VEGF isoform expression
is not known but is likely related to transcriptional and/
or post-transcriptional regulation of the VEGF gene which
results in different ratios of angiogenic to inhibitory VEGF
isoforms expressed.
One role of the inhibitory VEGF isoforms may be to inhibit the chemoattractant gradient and inhibit endothelial
cell migration (Bates et al. 2002; Woolard et al. 2004). Our
laboratory has subcloned and sequenced the rat VEGF165b
and determined that there is a sex-specific expression of
VEGF165b (fourfold higher in ovary than testis; unpublished data) during the time endothelial cell migration occurs. Therefore, the VEGF165b isoform may be expressed
in the ovary to prevent establishment of a chemoattractant
gradient and migration of endothelial cells from the mesonephros into the developing ovary.
How are specific VEGF isoform actions regulated?
Neuropilin1, a VEGFA co-receptor, appears to modulate VEGFA signal transduction (Klagsbrun and Eichmann 2005). Neuropilins were first identified as receptors
for axon guidance forming complexes with the plexinA subfamily to modulate semaphorin signals (Takahashi
et al. 1998). However, recent studies have identified a role
for neuropilins in VEGF-dependent angiogenic processes.
Specifically, NRP1 knockout mice have vasculature, heart
and neural defects and die at E10.5–12.5 suggesting that
NRP1 is necessary for normal vascular development (Kawasaki et al. 1999). If NRP1 binds to semaphorin instead of
VEGF then endothelial cell migration is inhibited (Miao et
al. 1999). Likewise, if NRP1/VEGF complexes bind to FLT1
this also may inhibit endothelial cell migration and the development of vasculature.
The predominant function of NRP1 appears to be stabilization of VEGFA164 binding to KDR which augments
signal transduction. The two co-receptors can also stabilize binding of angiogenic VEGFA isoforms to FLT1. Infact,
FLT1 may regulate angiogenic VEGF actions by enticing
NRP bound isoforms to bind to this decoy receptor. While
both NRP co-receptors can bind to FLT1 it appears that
only NRP1 can stabilize signal transduction through KDR.
Initially, VEGFA isoforms containing exon 7 or a heparin binding domain (also in exon 6) were thought to bind to
NRP1. However, there have been recent studies that suggest NRPs (in addition to binding to VEGF164 and 188 that
contain heparin binding domains) also bind to VEGFA120
(which does not have a heparin binding domain). Although
they bind VEGFA120, the interaction does not allow for the
bridging of the two receptors (NRP1 and KDR) that occur with VEGF164 or 188. Therefore, the interaction with
VEGF120 does not appear to stabilize and amplify signal
transduction which occurs with VEGF164 (Pan et al. 2007).
Exon 8a also appears to be important in binding of NRPs
to VEGF angiogenic isoforms (Jia et al. 2006). It has been
demonstrated that inhibitory VEGF isoforms such as 165b
cannot bind NRPs since exon 8b replaces 8a. Therefore,
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NRPs can convey angiogenic vs inhibitory isoform specificity to cells and if NRPs are eliminated from cells then the
actions of angiogenic isoforms may be impaired.
What regulates VEGF gene expression?
Hypoxia (Schweda et al. 2000), oestradiol (Mueller et al.
2000), progesterone (Mueller et al. 2003), and factors signalling through the SMAD signal transduction pathway
(He and Chen 2005) have all been implicated in increased
or decreased expression of VEGF isoforms. Results from in
vitro studies (Activin A/B, BMPs, AMH) (Yao et al. 2004)
and null mice (Inhbb, Follistatin and Wnt4) (Yao et al. 2004,
2006) suggest that TGF-β family members or proteins that
inhibit their actions are involved in modulation of vascular
development in the developing gonad. Interestingly, in the
zebrafish SMAD response elements regulate VEGF gene expression (He and Chen 2005). Deletion of either SMAD1 or
SMAD5 response elements on the zebrafish VEGF promoter
resulted in either inhibition or enhanced transcription of
the VEGF gene (He and Chen 2005). Within the murine
VEGF promoter there are multiple consensus sequences for
SMAD response elements (AS Cupp, unpublished data).
Therefore, it is highly possible that growth factors signalling through the SMAD signal transduction pathways alter
the expression of VEGF and VEGF-signal transduction mediators or potentially affect post-translational modification
of VEGF to allow for different ratios of angiogenic vs inhibitory isoforms to be expressed (Figure 2).
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to malnutrition (Qiu et al. 2007). However, until a testisspecific knockout mouse is developed it is unclear how removal of Sertoli-cell secretion of VEGF will affect testis development and function. Thus, further experiments need to
be conducted in vivo to demonstrate the role of VEGF on
sex-specific vascular development, seminiferous cord formation and testis function.
Conclusion
Approximately 2 million couples seek treatment for infertility every year and less than half find successful treatments
(Carlsen et al. 2005). Infertility problems in at least half of
these couples are a result of male-related factors that are
created by testicular dysgenesis. Many of the problems associated with testicular dysgenesis are proposed to involve
a disruption in embryonic differentiation of cells within the
indifferent gonad resulting in altered testicular development. Elucidating the factors involved in sex-specific vascular development will allow for a better understanding of
how transcription factors coordinate regulation of growth
factors to result in a testis-specific vascular system. Furthermore, delineating the interaction of VEGF angiogenic
and inhibitory isoforms in sex-specific vascular development promises to be an interesting piece in the puzzle of
gonadal development.
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What Mouse Models Can Be Used to Understand the
Function of VEGF During Testis Morphogenesis?
Null mutations of VEGF are embryonic lethal with even the
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